Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 70771-1627

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 70771-1627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

11 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 01)

11 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 01)
This is information on Tofacitinib Extended-Release tablets stored at controlled room temperature. The tablets should not be repackaged and kept out of children's reach. Pharmacists should dispense the medication with the separate patient guide provided. For further details, the medication guide is available online or through a helpline number.*
FDA Label Image

22 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 02)

22 mg (7e9346bb C19d 43dc 90dd 6a99ad184add 02)
This text appears to be a description of a medication. It provides information on the packaging, storage instructions, dosage, and company details. The medication mentioned is likely an extended-release tablet called Tofacitinib. It should be stored at a temperature between 15°C to 30°C and kept out of reach of children. The medication comes in a package containing 30 tablets. The text also includes the National Drug Code (NDC) and contact information for the company.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.